المؤلفون: Won Seog Kim, Muhit Ozcan, Roncero Jm, Tamás Masszi, Anne Lennard, Eric D. Jacobsen, Steven M. Horwitz, Lorenz Trümper, Juliana Pereira, EJ Leonard, Francine M. Foss, Anne W. Beaven, John P. Leonard, Karthik Venkatakrishnan, Rod Ramchandren, C.S. Chiattone, Mehmet Turgut, Claudio Dansky Ullmann, Lumiere Study Investigators, Owen A. O'Connor, Judith Trotman, Judit Demeter, Andrei R. Shustov, Hua Liu, Nelson Hamerschlak, Sheldon-Waniga E, Eric D. Hsi, Francesco d'Amore, Dolores Caballero, P. L. Zinzani

المساهمون: O'Connor, Owen A, Özcan, Muhit, Jacobsen, Eric D, Roncero, Josep M, Trotman, Judith, Demeter, Judit, Masszi, Tamá, Pereira, Juliana, Ramchandren, Radhakrishnan, Beaven, Anne, Caballero, Dolore, Horwitz, Steven M, Lennard, Anne, Turgut, Mehmet, Hamerschlak, Nelson, d'Amore, Francesco A, Foss, Francine, Kim, Won-Seog, Leonard, John P, Zinzani, Pier Luigi, Chiattone, Carlos S, Hsi, Eric D, Trümper, Lorenz, Liu, Hua, Sheldon-Waniga, Emily, Ullmann, Claudio Dansky, Venkatakrishnan, Karthik, Leonard, E Jane, Shustov, Andrei R, Lumiere Study Investigators, OMÜ

المصدر: Journal of Clinical Oncology
O'Connor, O A, Özcan, M, Jacobsen, E D, Roncero, J M, Trotman, J, Demeter, J, Masszi, T, Pereira, J, Ramchandren, R, Beaven, A, Caballero, D, Horwitz, S M, Lennard, A, Turgut, M, Hamerschlak, N, d'Amore, F A, Foss, F, Kim, W-S, Leonard, J P, Zinzani, P L, Chiattone, C S, Hsi, E D, Trümper, L, Liu, H, Sheldon-Waniga, E, Ullmann, C D, Venkatakrishnan, K, Leonard, E J, Shustov, A R & Lumiere Study Investigators 2019, ' Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma ', Journal of Clinical Oncology, vol. 37, no. 8, pp. 613-623 . https://doi.org/10.1200/JCO.18.00899

مصطلحات موضوعية: Male, Oncology, PHARMACOKINETICS, Cancer Research, Time Factors, KINASE INHIBITOR ALISERTIB, chemistry.chemical_compound, 0302 clinical medicine, AURORA KINASE, Recurrence, Single agent, Aurora Kinase A, Aged, 80 and over, Refractory Peripheral T-cell Lymphoma, 0303 health sciences, MLN8237, ORIGINAL REPORTS, Azepines, Middle Aged, APOPTOSIS, 3. Good health, 030220 oncology & carcinogenesis, Early Termination of Clinical Trials, Disease Progression, AUTOPHAGY, Female, EPITHELIAL OVARIAN, Adult, medicine.medical_specialty, Aurora A kinase, Antineoplastic Agents, Peripheral T-Cell Lymphoma, Alisertib, Disease-Free Survival, SIGNALING PATHWAYS, Young Adult, 03 medical and health sciences, Internal medicine, Hematologic Malignancy, medicine, BREAST-CANCER, Humans, In patient, Protein Kinase Inhibitors, Aged, 030304 developmental biology, MESENCHYMAL TRANSITION, business.industry, Lymphoma, T-Cell, Peripheral, Pyrimidines, chemistry, Drug Resistance, Neoplasm, Alisertib, business

وصف الملف: STAMPA; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798208f6ac14caadff6bb3de4243f18f
https://doi.org/10.1200/jco.18.00899

المؤلفون: Sagues, M, Xicoy, B, Estrada, N, Zamora, L, Buxo, M, Bustins, A, Diaz, J, Coll, R, Guardia, R, Cruz, D, Moret, C, Roncero, JM, Gonzalez, Y, Santos, N, Blanco, A, Kelleher, N, Lloveras, N, Mostacedo, S, Buch, J, Costa, P, Tejerina, P, Marull, A, Serrando, M, Tuset, E, Gallardo, D

المصدر: Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::ab9f5d0e40c3bbb4c508c421a48a1d65
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6452

المؤلفون: Sagues, M, Zamora, L, Xicoy, B, Estrada, N, Bustins, A, Diaz, J, Cruz, D, Moret, C, Costa, P, Buxo, M, Tejerina, P, Marull, A, Serrando, M, Roncero, JM, Gonzalez, Y, Santos, N, Blanco, A, Kelleher, N, Lloveras, N, Mostacedo, S, Coll, R, Guardia, R, Buch, J, Tuset, E, Gallardo, D

المصدر: Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::33050007695a88b701c9dc3ec76f37eb
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6370

المؤلفون: Delgado, J, Espinet, B, Oliveira, AC, Abrisqueta, P, de la Serna, J, Collado, R, Loscertales, J, Lopez, M, Hernandez-Rivas, JA, Ferra, C, Ramirez, A, Roncero, JM, Lopez, C, Aventin, A, Puiggros, A, Abella, E, Carbonell, F, Costa, D, Carrio, A, Gonzalez, M

المصدر: BRITISH JOURNAL OF HAEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: 17p, TP53, chronic lymphocytic leukaemia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8aff89c2503704de911c79fa71b45254
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11416

المؤلفون: Villavicencio, Alicia, Solans, Marta, Zacarías-Pons, Lluís, Vidal, Anna, Puigdemont, Montse, Roncero, Josep Maria, Saez, Marc, Marcos-Gragera, Rafael, Universitat Autònoma de Barcelona

المساهمون: Institut Català de la Salut, [Villavicencio A] Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Girona, Spain. Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. [Solans M] Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Zacarías-Pons Ll] Research Group on Aging, Disability and Health, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. [Vidal A, Puigdemont M] Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Girona, Spain. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. [Roncero JM] Departament d’Hematologia, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. [Saez M] Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain. Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Marcos-Gragera R] Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Girona, Spain. Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Josep Carreras Leukemia Research Institute, Badalona, Spain, Hospital Universitari de Girona Dr Josep Trueta

المصدر: International Journal of Environmental Research and Public Health
Volume 18
Issue 2
International Journal of Environmental Research and Public Health, 2021, vol. 18, núm. 2, p. 701
Articles publicats (D-EC)
DUGiDocs – Universitat de Girona
instname
International Journal of Environmental Research and Public Health, Vol 18, Iss 701, p 701 (2021)
Scientia

مصطلحات موضوعية: Multivariate analysis, Other subheadings::Other subheadings::/epidemiology [Other subheadings], Health, Toxicology and Mutagenesis, Chronic lymphocytic leukemia, lcsh:Medicine, Comorbidity, 0302 clinical medicine, immune system diseases, Cause of Death, hemic and lymphatic diseases, Medicine, ambiente y salud pública::salud pública::factores epidemiológicos::comorbilidad [ATENCIÓN DE SALUD], Cause of death, education.field_of_study, Leucèmia limfoide, Relative survival, Otros calificadores::Otros calificadores::/epidemiología [Otros calificadores], Leucèmia limfoide - Epidemiologia, Leucèmia limfoide -- Mortalitat, 030220 oncology & carcinogenesis, neoplasias::neoplasias por tipo histológico::leucemia::leucemia linfoide::leucemia de células B::leucemia linfocítica crónica de células B [ENFERMEDADES], medicine.medical_specialty, Population, Mort - Causes, causes of death, comorbidities, survival, Article, 03 medical and health sciences, Comorbiditat, Diabetes mellitus, Internal medicine, Humans, Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Comorbidity [HEALTH CARE], education, Proportional Hazards Models, business.industry, lcsh:R, Public Health, Environmental and Occupational Health, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Cancer registry, population-based, Lymphocytic leukemia, Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Lymphoid::Leukemia, B-Cell::Leukemia, Lymphocytic, Chronic, B-Cell [DISEASES], Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Cause of Death [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Lymphocytic leukemia -- Mortality, Spain, chronic lymphocytic leukemia, business, técnicas de investigación::métodos epidemiológicos::recopilación de datos::estadísticas vitales::mortalidad::causas de muerte [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], 030215 immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a4dc08d7397b843c286430e0780f04

المؤلفون: Oliveira AC; Department of Clinical Hematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, IDIBELL, Gran Vía 199-203, Hospitalet, 08908, Barcelona, Spain. acoliveira@iconcologia.net., Roncero JM; Department of Clinical Hematology, ICO-Hospital Josep Trueta, Girona, Spain., Ferrá C; Department of Clinical Hematology, ICO-Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain., Do Nascimento J; Department of Clinical Hematology, ICO-Hospital Joan XXIII, Tarragona, Spain., Rodriguez-Luaces M; Department of Clinical Hematology, ICO-Hospital Verge de la Cinta, Tortosa, Tarragona, Spain., Encuentra M; Clinical Research Unit, ICO-Hospital Duran i Reynals, IDIBELL, Hospitalet, Barcelona, Spain., Domingo-Domenech E; Department of Clinical Hematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, IDIBELL, Gran Vía 199-203, Hospitalet, 08908, Barcelona, Spain., López P; Department of Clinical Hematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, IDIBELL, Gran Vía 199-203, Hospitalet, 08908, Barcelona, Spain., Gallardo D; Department of Clinical Hematology, ICO-Hospital Josep Trueta, Girona, Spain., Ribera JM; Department of Clinical Hematology, ICO-Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain., Sarrá J; Department of Clinical Hematology, ICO-Hospital Joan XXIII, Tarragona, Spain., Sureda A; Department of Clinical Hematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, IDIBELL, Gran Vía 199-203, Hospitalet, 08908, Barcelona, Spain., González-Barca E; Department of Clinical Hematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, IDIBELL, Gran Vía 199-203, Hospitalet, 08908, Barcelona, Spain.

المصدر: International journal of hematology [Int J Hematol] 2023 Mar; Vol. 117 (3), pp. 388-397. Date of Electronic Publication: 2022 Nov 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/etiology, Humans ; Rituximab ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide ; Vidarabine

المؤلفون: Roncero JM; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain., Álvarez-Ortí M; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain., Pardo-Giménez A; Mushroom Research, Experimentation and Service Centre, C/Peñicas, s/n, Apartado 63, 16220 Quintanar del Rey, Spain., Rabadán A; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain., Pardo JE; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain.

المصدر: Foods (Basel, Switzerland) [Foods] 2021 May 11; Vol. 10 (5). Date of Electronic Publication: 2021 May 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101670569 Publication Model: Electronic Cited Medium: Print ISSN: 2304-8158 (Print) Linking ISSN: 23048158 NLM ISO Abbreviation: Foods Subsets: PubMed not MEDLINE

المؤلفون: Villavicencio A; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Carrer del Sol 15, 17004 Girona, Spain; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, C/ Universitat de Girona 10, 17003 Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain., Solans M; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, C/ Universitat de Girona 10, 17003 Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Av. Monforte de Lemos 3-5, 28029 Madrid, Spain. Electronic address: marta.solans@udg.edu., Auñon-Sanz C; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Radiation Oncology Service, Josep Trueta University Hospital, Catalan Institute of Oncology, Avinguda de França, S/N, 17007 Girona, Spain., Roncero JM; Hematological Service, Josep Trueta University Hospital, Catalan Institute of Oncology, Avinguda de França, S/N, 17007 Girona, Spain., Marcos-Gragera R; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Carrer del Sol 15, 17004 Girona, Spain; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, C/ Universitat de Girona 10, 17003 Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Av. Monforte de Lemos 3-5, 28029 Madrid, Spain; Josep Carreras Leukemia Research Institute, Girona, Spain.

المصدر: Cancer epidemiology [Cancer Epidemiol] 2020 Dec; Vol. 69, pp. 101841. Date of Electronic Publication: 2020 Nov 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101508793 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-783X (Electronic) Linking ISSN: 18777821 NLM ISO Abbreviation: Cancer Epidemiol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma/*epidemiology , Lymphoma/*mortality, Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Registries ; Spain ; Survival Analysis ; Time Factors ; Young Adult

المؤلفون: Roncero JM; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain., Álvarez-Ortí M; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain., Pardo-Giménez A; Mushroom Research, Experimentation and Service Centre, C/Peñicas, s/n, Apartado 63, Quintanar del Rey, 16220 Cuenca, Spain., Rabadán A; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain., Pardo JE; Higher Technical School of Agricultural and Forestry Engineering, University of Castilla-La Mancha, Campus Universitario, s/n, 02071 Albacete, Spain.

المصدر: Foods (Basel, Switzerland) [Foods] 2020 Nov 11; Vol. 9 (11). Date of Electronic Publication: 2020 Nov 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101670569 Publication Model: Electronic Cited Medium: Print ISSN: 2304-8158 (Print) Linking ISSN: 23048158 NLM ISO Abbreviation: Foods Subsets: PubMed not MEDLINE

المؤلفون: O'Connor OA; 1 Columbia University Medical Center, New York, NY., Özcan M; 2 Ankara University Medical School, Ankara, Turkey., Jacobsen ED; 3 Dana-Farber Cancer Institute, Boston, MA., Roncero JM; 4 Institut Català d'Oncologia de Girona, Girona, Spain., Trotman J; 5 Concord Repatriation General Hospital, Concord, New South Wales, Australia.; 6 University of Sydney, New South Wales, Australia., Demeter J; 7 Semmelweis Egyetem Általános Orvostudományi Kar, Budapest, Hungary., Masszi T; 8 St. István and St. László Hospital, Budapest, Hungary.; 9 Semmelweis University, Budapest, Hungary., Pereira J; 10 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Ramchandren R; 11 Karmanos Cancer Institute, Detroit, MI., Beaven A; 12 Duke University Health System, Durham, NC., Caballero D; 13 Hospital Universitario de Salamanca, Salamanca, Spain., Horwitz SM; 14 Memorial Sloan Kettering Cancer Center, New York, NY., Lennard A; 15 Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom., Turgut M; 16 Ondokuz Mayis University, Samsun, Turkey., Hamerschlak N; 17 Hospital Israelita Albert Einstein, Sao Paulo, Brazil., d'Amore FA; 18 Aarhus Universitetshospital, Aarhus, Denmark., Foss F; 19 Smilow Cancer Hospital at Yale New Haven, New Haven, CT., Kim WS; 20 Sungkyunkwan University School of Medicine, Seoul, South Korea., Leonard JP; 21 Weill Cornell Medical College, New York, NY., Zinzani PL; 22 University of Bologna, Bologna, Italy., Chiattone CS; 23 Santa Casa Medical School, São Paulo, Brazil., Hsi ED; 24 Cleveland Clinic, Cleveland, OH., Trümper L; 25 University Medical Center Göttingen, Göttingen, Germany., Liu H; 26 Millennium Pharmaceuticals, Cambridge, MA., Sheldon-Waniga E; 26 Millennium Pharmaceuticals, Cambridge, MA., Ullmann CD; 26 Millennium Pharmaceuticals, Cambridge, MA., Venkatakrishnan K; 26 Millennium Pharmaceuticals, Cambridge, MA., Leonard EJ; 26 Millennium Pharmaceuticals, Cambridge, MA., Shustov AR; 27 University of Washington, Seattle Cancer Care Alliance, Seattle, WA.

مؤلفون مشاركون: Lumiere Study Investigators

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Mar 10; Vol. 37 (8), pp. 613-623. Date of Electronic Publication: 2019 Feb 01.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Aurora Kinase A/*antagonists & inhibitors , Azepines/*therapeutic use , Lymphoma, T-Cell, Peripheral/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , Pyrimidines/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Aurora Kinase A/metabolism ; Azepines/adverse effects ; Disease Progression ; Disease-Free Survival ; Drug Resistance, Neoplasm ; Early Termination of Clinical Trials ; Female ; Humans ; Lymphoma, T-Cell, Peripheral/diagnosis ; Lymphoma, T-Cell, Peripheral/enzymology ; Lymphoma, T-Cell, Peripheral/mortality ; Male ; Middle Aged ; Protein Kinase Inhibitors/adverse effects ; Pyrimidines/adverse effects ; Recurrence ; Time Factors ; Young Adult